# Omics Data at Scale

for Life Sciences Research

Ovation provides life sciences R&D teams access to high-value omics data linked to rich, longitudinal clinical data, across therapeutic areas, at population scale.

Ovation’s data increases the probability of success for drug discovery by enabling the identification and validation of biomarkers and therapeutic targets.

You can also check out our latest research and data sheets:

- [**About Ovation’s IBD Omics Data**](https://connect.ovation.io/hubfs/Sales%20Enablement/IBD_Genomic_Data_230404.pdf)
- [**Crohn’s & Colitis Congress 2024 Poster**](https://connect.ovation.io/hubfs/Academic%20Posters/Ovation%20Crohns%20&%20Colitis%20Congress%202024%20Poster.pdf)

## Get Started with Ovation

#### Explore a sample of Ovation’s IBD Omics Data on [AWS Data Exchange

## Additional Resources

##### Blogs

[Unlocking the Value of Transcriptomics in IBD R&D](https://www.ovation.io/unlocking-the-value-of-transcriptomics-in-ibd-rd/)

[How Omics Data Can Accelerate Precision Medicine for IBD](https://www.ovation.io/how-omics-data-can-accelerate-precision-medicine-for-ibd/)

##### Webinars

[Linking Genomic and Phenotypic Data to Better Understand the Patient Journey](https://www.ovation.io/linking-genomic-and-phenotypic-data/)

#### Ovation and DNAnexus Present at the 2nd Precision Medicine in IBD Summit

Learn about the transformative power of leveraging high-value multiomics data alongside an advanced..

#### Linking Genomic and Phenotypic Data to Better Understand the Patient Journey

In partnership with Datavant, we explore how researchers can overcome the challenges posed by..

_[Ovation Reaches 10,000 GLP-1 Clinicogenomic Patient Milestone, Now Available for Licensing – Read More →](https://www.ovation.io/ovation-reaches-10000-glp-1-clinicogenomic-patient-milestone-now-available-for-licensing/)_